|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000031912 |
| Receipt No. | R000036441 |
| Scientific Title | Phase 1 study of YM155, novel selective survivin suppressant in combination with elrotinib in patients with EGFR-mutant advanced non-small-cell lung cancer |
| Date of disclosure of the study information | 2018/03/27 |
| Last modified on | 2018/03/26 23:38:32 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2018/03/26 23:39:25 |
